SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,218,624.4003947. The last known price of Ethereum is 1,739.90377069 USD and is down -9.84 over the last 24 hours. It is currently trading on 14359 active market(s) with $18,820,901,710.98 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is caught in a sharp, broad crypto selloff alongside Bitcoin and other tokens, with traders frequently pointing to forced liquidations and weak demand. The community is split between viewing the decline as capitulation and a buying opportunity and expecting further losses; proposed explanations such as macro risk-off and competition for IPO capital remain speculation.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins sharp decline is driving pressure on Strategy, which traders view as a leveraged proxy for BTC; many fear further downside and speculate about forced selling or financial strain, while some see the selloff as a buying opportunity. Traders also cite Strategys announced MSCI index removal as a potential source of additional selling pressure.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,752,062,860.16806072. The last known price of Dogecoin is 0.05689686 USD and is down -11.89 over the last 24 hours. It is currently trading on 1545 active market(s) with $1,128,721,930.78 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoin is drawing attention amid a sharp decline alongside the broader crypto market, with traders pointing to persistent selling and multi-year lows. The community is split between treating the weakness as a buying opportunity and warning that the selloff could deepen, with some linking DOGEs moves to Bitcoin.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 0.92173784 USD and is down -8.73 over the last 24 hours. It is currently trading on 1896 active market(s) with $4,059,642,828.82 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

A broad crypto selloff, with traders linking XRPs decline to Bitcoin weakness and market-wide liquidations, has pushed the token below $1 and to reported yearly lows. The community is split between buying the dip and expecting further losses, with some also citing macroeconomic and political concerns without a clear consensus on a specific catalyst.

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 637,554,569.48929238 with 591,573,607.37721086 in circulation. The last known price of Solana is 69.50906472 USD and is down -10.60 over the last 24 hours. It is currently trading on 1189 active market(s) with $4,775,978,662.51 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is drawing attention amid a sharp drop alongside broader crypto weakness, with traders discussing sustained selling, a possible downtrend and whether support will hold. The community is split between bearish calls for further losses and investors buying and staking the dip.

Avalanche (AVAX) is a cryptocurrency launched in 2020. Avalanche has a current supply of 471,438,169.1160568 with 446,436,169.1160568 in circulation. The last known price of Avalanche is 6.99518175 USD and is down -15.00 over the last 24 hours. It is currently trading on 1135 active market(s) with $402,139,637.32 traded over the last 24 hours. More information can be found at https://avax.network/.

Avalanche

AVAX is drawing attention for a steep selloff alongside weakness across Bitcoin and altcoins, with traders describing it as especially weak and watching whether it falls below support. The reaction is split between frustrated holders expecting further declines and buyers treating the dip as an accumulation opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Norwalk, CT.

BitMine Immersion Technologies Inc

Ethereum and broader crypto weakness is weighing on BitMine, whose large ETH treasury ties its shares closely to the tokens performance. Traders largely express frustration with the decline and Tom Lees bullish calls, while some argue the discount to asset value and potential buybacks make the selloff an opportunity.

Litecoin (LTC) is a cryptocurrency . Users are able to generate LTC through the process of mining. Litecoin has a current supply of 84,000,000 with 77,830,936.34364598 in circulation. The last known price of Litecoin is 43.58319249 USD and is down -11.87 over the last 24 hours. It is currently trading on 1567 active market(s) with $330,181,316.06 traded over the last 24 hours. More information can be found at https://litecoin.org/.

Litecoin

Litecoins sharp selloff alongside broader crypto weakness is driving attention, with traders criticizing its relative underperformance and warning of further downside. Others view the decline as a buying opportunity and are accumulating, leaving sentiment divided between fears of a breakdown and hopes for a rebound.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin Trust ETF

Bitcoins sharp pullback and break below key technical support are weighing on IBIT, with traders debating whether weakness will deepen or mark an oversold low. Bearish posts warn of further losses amid risk-off trading and ETF redemptions, while some holders view the decline as a dip-buying opportunity.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPaths steep selloff after investor-day-related analyst downgrades is driving attention, with concerns about slowing growth, AI pricing and competition weighing on sentiment. Bulls argue the companys agentic-AI and orchestration strategy is undervalued, while skeptics want clearer evidence that it can translate into stronger recurring revenue and customer adoption.

statis crypto Watchlist

Bitcoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Innovative Immunology Biotech Windward Bio Lists on Nasdaq Innovative Immunology Biotech Windward Bio Lists on NasdaqPR NewswireSHANGHAI, Nov. 14, 2026 SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company...

Its lead programs target thymic stromal lymphopoietin and interleukin-13 and are in clinical development. Windward Bio Group AG is a Swiss clinical-stage biotechnology company founded in 2024 that develops ultra-long-acting monoclonal antibodies for serious respiratory and dermatologic immunological diseases, including asthma, chronic obstructive pulmonary disease, and atopic dermatitis.

Windward Bio Group AG

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

WWB Windward Bio Group AG

Fundamentals

Latest WWB News